Pacific Shuanglin Bio pharmacy Co Ltd (000403) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥70.28 Million ≈ $10.28 Million USD) by net assets (CN¥8.03 Billion ≈ $1.17 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Pacific Shuanglin Bio pharmacy Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Pacific Shuanglin Bio pharmacy Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Pacific Shuanglin Bio pharmacy Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pacific Shuanglin Bio pharmacy Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pacific Shuanglin Bio pharmacy Co Ltd ranked by their cash flow conversion efficiency. Explore Pacific Shuanglin Bio pharmacy Co Ltd (000403) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Israel Canada
TA:ISCN
-0.076x
Telkom
JSE:TKG
0.176x
Mota-Engil SGPS S.A
LS:EGL
0.095x
Xior Student Housing NV
BR:XIOR
0.032x
China Merchants Property Operation & Service Co Ltd
SHE:001914
0.256x
GoGold Resources Inc.
TO:GGD
0.052x
Alimak Hek Group AB
ST:ALIG
0.115x
Pabrik Kertas Tjiwi Kimia Tbk
JK:TKIM
-0.011x

Annual Cash Flow Conversion Efficiency for Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Pacific Shuanglin Bio pharmacy Co Ltd from 1998 to 2025. View 000403 share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥8.08 Billion
≈ $1.18 Billion
CN¥-215.99 Million
≈ $-31.61 Million
-0.027x -165.76%
2024-12-31 CN¥7.92 Billion
≈ $1.16 Billion
CN¥321.79 Million
≈ $47.09 Million
0.041x -55.58%
2023-12-31 CN¥7.42 Billion
≈ $1.09 Billion
CN¥679.01 Million
≈ $99.36 Million
0.091x +19.74%
2022-12-31 CN¥6.86 Billion
≈ $1.00 Billion
CN¥524.22 Million
≈ $76.71 Million
0.076x +18.43%
2021-12-31 CN¥6.33 Billion
≈ $925.95 Million
CN¥408.22 Million
≈ $59.74 Million
0.065x -67.99%
2020-12-31 CN¥966.91 Million
≈ $141.49 Million
CN¥194.84 Million
≈ $28.51 Million
0.202x -15.36%
2019-12-31 CN¥801.60 Million
≈ $117.30 Million
CN¥190.84 Million
≈ $27.93 Million
0.238x +26.45%
2018-12-31 CN¥619.48 Million
≈ $90.65 Million
CN¥116.63 Million
≈ $17.07 Million
0.188x +393.01%
2017-12-31 CN¥558.88 Million
≈ $81.78 Million
CN¥-35.91 Million
≈ $-5.26 Million
-0.064x -156.24%
2016-12-31 CN¥546.91 Million
≈ $80.03 Million
CN¥62.49 Million
≈ $9.14 Million
0.114x -14.61%
2015-12-31 CN¥525.49 Million
≈ $76.90 Million
CN¥70.31 Million
≈ $10.29 Million
0.134x -20.34%
2014-12-31 CN¥458.65 Million
≈ $67.11 Million
CN¥77.04 Million
≈ $11.27 Million
0.168x -35.09%
2013-12-31 CN¥351.68 Million
≈ $51.46 Million
CN¥91.01 Million
≈ $13.32 Million
0.259x -39.60%
2012-12-31 CN¥287.68 Million
≈ $42.10 Million
CN¥123.24 Million
≈ $18.03 Million
0.428x -6.92%
2011-12-31 CN¥282.74 Million
≈ $41.37 Million
CN¥130.14 Million
≈ $19.04 Million
0.460x +1176.66%
2010-12-31 CN¥274.00 Million
≈ $40.09 Million
CN¥9.88 Million
≈ $1.45 Million
0.036x -95.56%
2009-12-31 CN¥137.64 Million
≈ $20.14 Million
CN¥111.86 Million
≈ $16.37 Million
0.813x +92.34%
2008-12-31 CN¥177.26 Million
≈ $25.94 Million
CN¥74.90 Million
≈ $10.96 Million
0.423x -95.59%
2007-12-31 CN¥9.92 Million
≈ $1.45 Million
CN¥95.03 Million
≈ $13.91 Million
9.578x +2397.05%
2006-12-31 CN¥-27.16 Million
≈ $-3.97 Million
CN¥-10.42 Million
≈ $-1.52 Million
0.384x -12.05%
2005-12-31 CN¥112.49 Million
≈ $16.46 Million
CN¥49.06 Million
≈ $7.18 Million
0.436x +299.35%
2004-12-31 CN¥602.14 Million
≈ $88.11 Million
CN¥-131.73 Million
≈ $-19.28 Million
-0.219x -271.64%
2003-12-31 CN¥840.33 Million
≈ $122.97 Million
CN¥-49.47 Million
≈ $-7.24 Million
-0.059x -128.81%
2002-12-31 CN¥779.03 Million
≈ $114.00 Million
CN¥159.18 Million
≈ $23.29 Million
0.204x +26.30%
2001-12-31 CN¥687.82 Million
≈ $100.65 Million
CN¥111.28 Million
≈ $16.28 Million
0.162x +254.33%
2000-12-31 CN¥599.28 Million
≈ $87.69 Million
CN¥27.36 Million
≈ $4.00 Million
0.046x +195.34%
1999-12-31 CN¥481.83 Million
≈ $70.51 Million
CN¥-23.08 Million
≈ $-3.38 Million
-0.048x -326.45%
1998-12-31 CN¥235.63 Million
≈ $34.48 Million
CN¥-2.65 Million
≈ $-387.22K
-0.011x --

About Pacific Shuanglin Bio pharmacy Co Ltd

SHE:000403 China Biotechnology
Market Cap
$1.37 Billion
CN¥9.39 Billion CNY
Market Cap Rank
#7619 Global
#1681 in China
Share Price
CN¥9.88
Change (1 day)
-0.30%
52-Week Range
CN¥8.79 - CN¥16.88
All Time High
CN¥49.14
About

Pacific Shuanglin Bio-pharmacy Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of blood products in China and internationally. The company offers human serum albumin, human immunoglobulin (PH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin, rabies immunoglobulin, human coagulation factor VIII, human fibrinogen… Read more